| Jon D Olson, MD | |
|
10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810-1686 | |
| (225) 769-2200 | |
| (225) 768-2185 |
| Full Name | Jon D Olson |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 31 Years |
| Location | 10101 Park Rowe Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619966819 | NPI | - | NPPES |
| 1557072 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 13226R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Spine Hospital Of Louisiana | Baton rouge, LA | Hospital |
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neuromedical Center | 6103716477 | 86 |
News Archive
A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
In a surprising finding, blacks and whites have the same risk of developing diabetes when all biological factors for the disease are considered over time, reports a large new Northwestern Medicine study.
› Verified 5 days ago
| Entity Name | Neuromedical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216399 PECOS PAC ID: 6103716477 Enrollment ID: O20040318001606 |
News Archive
A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
In a surprising finding, blacks and whites have the same risk of developing diabetes when all biological factors for the disease are considered over time, reports a large new Northwestern Medicine study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jon D Olson, MD Po Box 98509, Baton Rouge, LA 70884-9509 Ph: (225) 769-2200 | Jon D Olson, MD 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810-1686 Ph: (225) 769-2200 |
News Archive
A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
In a surprising finding, blacks and whites have the same risk of developing diabetes when all biological factors for the disease are considered over time, reports a large new Northwestern Medicine study.
› Verified 5 days ago
Dr. Donna Brian Fargason, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9311a Bluebonnet Blvd, Baton Rouge, LA 70810 Phone: 225-769-5551 Fax: 225-769-5583 | |
Kishore M Gadde, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6400 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-763-2552 | |
Joseph Anthony Grizzaffi Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5131 Odonovan Dr, Ste 300, Baton Rouge, LA 70808 Phone: 225-374-0400 Fax: 225-374-0430 | |
Abdul Baset Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9001 Summa Ave, Baton Rouge, LA 70809 Phone: 225-761-5200 Fax: 225-761-5654 | |
Gerard Dynes, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Dr. Kari Akili Jones, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7521 Kings Hill Ave, Baton Rouge, LA 70810 Phone: 225-267-7141 | |
Dr. Ashok Reddy Polu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-6565 |